FDA Considers Overhauling Its Regulation of Homeopathic Products for the First Time in 25 Years, by Elisabeth Ulmer
On March 27, 2015, the Food and Drug Administration (“FDA”) posted a notice of public hearing and request for comments about “the current use of human drug and biological products labeled as homeopathic, as well as the Agency’s regulatory framework for such products.” The FDA took this action because the previously limited homeopathic drug market […]